samedan logo
 
 
 
spacer
home > pmps > winter 2001 > in outsourcing - a new paradigm in supply chain management
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

In Outsourcing - A New Paradigm in Supply Chain Management

The leader of a large pharmaceutical company once asked the question: "How do pharmaceutical companies effectively integrate outsourcing partners into an already sub-optimised set of supply-chain processes?" Most pharmaceutical executives will agree that the pharmaceutical industry as a whole has not embraced 'operational excellence'. Their focus has been on the development of technology and new and innovative blockbuster drugs.

However, recent cost pressures, expiring patents and increased government regulations have changed the content of many boardroom discussions. Executive discussions have started to centre around effective planning, supplier partnerships, internal and external development and manufacturing excellence, and global distribution capabilities. In comparison with other industries, supply chain management in the pharmaceutical industry is still a relatively new concept.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Keith Clinkscales of PA Consulting Group
Keith Clinkscales is a Member of PA Consulting Group's management team, responsible for developing PA's global life sciences and technology business in North America. Keith has served as an industry professional and consultant in pharmaceutical and high-tech industries for more than 15 years and has particular expertise in the procurement and supply chain areas.

spacer
Keith Clinkscales
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma and Memo Therapeutics AG collaborate on the fast-track manufacturing of a SARS-CoV-2- neutralizing antibody for the therapy of COVID-19

Vilnius, Lithuania, and Schlieren, Switzerland August 11, 2020 Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Swiss biotech company Memo Therapeutics AG (MTx), announce a new partnership to manufacture MTxs therapeutic COVID-19 antibody candidate in a 4-month fast-track process approved by regulatory authorities.
More info >>

White Papers

Technology Solutions - Driving efficiencies, quality and operational excellence

Worldwide Clinical Trials Ltd

Clinical trials involve the entry, analysis and reporting of millions of pieces of data; year-on-year, the amount of data required to manage efficacy and safety increases exponentially. Recently, solutions available to support this activity have grown in numbers and complexity. The rise of Tablets and Smart Phones combined with the growth of Cloud or SAS solutions has resulted in the technology landscape required to support complex, global studies becoming more confusing.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement